Arbutus Biopharma ABUS
NASDAQ ABUS
$4.45 -0.11 (-2.52%)
As of: Oct 2, 2026 · 9:39 AM EDT

Arbutus Biopharma (ABUS) Price to Earnings (2026)

Updated

Arbutus Biopharma's (ABUS) Price to Earnings was 6.20 for Q2 2026, up 12.4% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Price to Earnings (2026) Analysis & Trends

For FY2012, Price to Earnings at Arbutus Biopharma was 2.38.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Arbutus Biopharma 944.69 Mn 571.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.20
Mar 31, 2026 5.51
API Access

Arbutus Biopharma Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABUS&period=max&api_key=YOUR_API_KEY